Antiproliferative activity of novel imidazopyridine derivatives on castration-resistant human prostate cancer cells

Metastatic prostate cancer (mPCa) relapses after a short period of androgen deprivation therapy and becomes the castration-resistant prostate cancer (CR PCa); to which the treatment is limited. Hence, it is imperative to identify novel therapeutic agents towards this patient population. In the prese...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Muniyan, Sakthivel, Chou, Yu-Wei, Ingersoll, Matthew A., Devine, Alexus, Morris, Marisha, Odero-Marah, Valerie A., Khan, Shafiq A., Chaney, William G., Bu, Xiu R., Lin, Ming-Fong
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4150829/
https://ncbi.nlm.nih.gov/pubmed/25050738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2014.07.002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky